Supplements

Guidelines supplements are written by experts and typically discuss a piece of national guidance, pulling out key learning points for GPs. Our range includes Guidance Update, Product Review, and Guidelines Handbook

20181203 Supplement v3 cover

Supporting smoking cessation in patients with COPD is the most effective intervention

2019-01-16T10:25:00+00:00Funded by Johnson and Johnson Limited

Information intended for healthcare professionals only.

Evidence Update - The IMPACT trial

A comparison of once-daily triple therapy with once-daily dual therapy in the treatment of symptomatic COPD—the IMPACT trial

2018-12-07T19:06:00+00:00Commissioned by GlaxoSmithKline

 

20180904 Flynn ADHD supplement v4

Recognising and managing adult ADHD in primary care

2018-11-22T09:48:00+00:00By Commissioned by Flynn Pharma Ltd.

Commissioned by Flynn Pharma Ltd.

20180831 Pain supplement

The role of morphine in the management of cancer pain

2018-10-03T15:17:00+01:00Commissioned by Ethypharm UK Ltd

Commissioned by Ethypharm UK Ltd

sign diabetes supplement

Type 2 diabetes: an overview of the SIGN guideline on pharmacological management of glycaemic control

2018-08-16T10:10:00+01:00Funded by Napp Pharmaceuticals Limited

Production of this Guidelines supplement has been funded by an educational grant from Napp Pharmaceuticals Limited. The grant included an honorarium for the author. Napp Pharmaceuticals Limited has reviewed the supplement for technical accuracy and to ensure compliance with regulations. Napp Pharmaceuticals Limited has had no input into or ...


Validate Accessibility